AmgenvsShoulder Innovations

AMGN and SI stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$462.32

Value $249B

-0.30%
AMGN's page

SI

Shoulder Innovations, Inc.

$20.45

Value $422M

-1.85%
SI's page

Amgen (AMGN) has a market value of $249B and Shoulder Innovations (SI) $422M. Over the last year, with dividends, AMGN moved +42.3% and SI +37.9%. Dividend yield: AMGN 2.15%, SI none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$249B

    SI$422M

    AMGN is 590 times SI

  • Revenue, 12 months

    AMGN$38.9B

    SI$64M

    AMGN is 603 times SI

  • Net income, 12 months

    AMGN$9.4B

    SI-$33M

  • Operating margin

    AMGN32.4%

    SI-54.4%

    86.8 points apart

  • ROIC

    AMGN16.2%

    SI-18.8%

    35.0 points apart

  • P/E

    AMGN26.5

    SI–

  • Dividend yield

    AMGN2.2%

    SI0.0%

    2.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+42.3%

SI+37.9%

80100120140DecFebAprJunAugOct
Returns by period
PeriodAMGNWith dividendsSIWith dividends
1 year since November 12, 2025+42.3%Price +38.5%+37.9%Price +37.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenSIShoulder Innovations

Valuation

AMGNSI
Valuation
Price$462.32$20.45
Market value$249B$422M
Enterprise value (EV)$290B$345M
P/E26.5–
P/E, 5-year median23.0–
P/B17.43.6
EV/EBIT23.0–
Free cash flow yield3.8%–

Results and growth

AMGNSI
Results and growth
Revenue, 12 months$38.9B$64M
Net income, 12 months$9.4B-$33M
Free cash flow, 12 months$9.6B-$43M
Earnings per share, 12 months$17.25$1.11
Revenue growth, year on year10.0%49.6%
Revenue growth a year, past+7.6%over 5 years+49.6%over 1 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNSI
Margins and returns on capital
Gross margin70.9%77.8%
Operating margin32.4%-54.4%
Net margin24.1%-51.7%
ROIC16.2%-18.8%
ROE87.8%-25.1%

Balance sheet

AMGNSI
Balance sheet
Cash$13.2B$92M
Total debt$54.0B$15M
Net debt / EBITDA2.3–
Interest cover4.8×–

Dividends and buybacks

AMGNSI
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or SI

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Shoulder Innovations?

By market value, Amgen ($249B) is about 590.2 times Shoulder Innovations ($422M), at today's prices.

How did AMGN and SI stock do over the last 1 years?

Since November 12, 2025, AMGN's price moved +38.5% and SI's +37.9%. With dividends: AMGN +42.3% (+42.3% a year), SI +37.9% (+37.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or SI?

The dividend yield at today's price is 2.15% for Amgen and none for Shoulder Innovations. Over the last twelve months they paid $9.94 and – per share.

Which has the higher profit margins, Amgen or Shoulder Innovations?

Over the last twelve months, the net margin was 24.1% for Amgen and -51.7% for Shoulder Innovations, and the operating margin 32.4% and -54.4%. Revenue was $38.9B and $64M.

Which is the better investment, Amgen or Shoulder Innovations?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.